Targeted Therapies in Urothelial Carcinoma

Learn how experts incorporate the newest targeted therapies and antibody–drug conjugates into optimal management of advanced progressive urothelial carcinoma with downloadable slides from a live CCO Webinar.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Immunomedics